Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Sofosbuvir–velpatasvir

Brand: Epclusa ®
NICE TA: 430
Indication: Sofosbuvir–velpatasvir for treating chronic hepatitis C (NICE TA430)
Disease category: Infections
Commissioning responsibility: NHSE
PbR excluded: Yes

Background

Sofosbuvir–velpatasvir is recommended as an option for treating chronic hepatitis C in adults, as specified in table, only if the company provides the drug with the discount agreed in the simple discount agreement.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA430 - Sofosbuvir–velpatasvir for treating chronic hepatitis C

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red